Posted on September 3rd, 2010 by Health News
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in [...]
No Comments »
Filed under: Pharmacy News
Posted on September 2nd, 2010 by Health News
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting [...]
No Comments »
Filed under: Pharmacy News
Posted on September 2nd, 2010 by Health News
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in [...]
No Comments »
Filed under: Pharmacy News
Posted on September 1st, 2010 by Health News
A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient…
No Comments »
Filed under: Women's Health
Posted on August 27th, 2010 by Health News
The Food and Drug Administration (FDA) has issued a Refuse to File letter for accelerated approval of Roche’s trastuzumab-DM1 (T-DM1) Biologics License Application, which was submitted in July 2010. Roche had requested accelerated approval for T-DM1 based on the results of a single-arm Phase II study. In that study one third of advanced HER2 positive [...]
No Comments »
Filed under: Pharmacy News
Posted on August 26th, 2010 by Health News
Plexxikon today announced publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatment of metastatic melanoma patients with the BRAF V600E mutation resulted in significant tumor shrinkage in the majority of patients. Specifically, in the melanoma extension cohort of the study, nearly all patients showed some response; 81 percent of [...]
No Comments »
Filed under: Pharmacy News
Posted on August 25th, 2010 by Health News
The Reproductive Science Center of the San Francisco Bay Area (RSC) is hoping to recruit 150 women suffering from uterine fibroids, benign tumors that can cause extreme pain and infertility. Fibroids are non-cancerous tumors or growths in the wall of the uterus. The cause of uterine fibroid tumors is unknown. Fifty percent of all women [...]
No Comments »
Filed under: Women's Health
Posted on August 24th, 2010 by Health News
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
No Comments »
Filed under: Pharmacy News
Posted on August 17th, 2010 by Health News
Merck is pleased to announce that New Brunswick, Nova Scotia and Alberta are the first provinces in Canada to reimburse SIMPONI(golimumab) for the treatment of three different rheumatic conditions. SIMPONI, a subcutaneous anti-tumor necrosis factor therapy, is now reimbursed by the drug formularies of these three provinces for people living with moderately to severely active [...]
No Comments »
Filed under: Pharmacy News
Posted on August 15th, 2010 by Health News
Although the use of ovarian tissue cryopreservation and transplantation has lead to 13 live births in women with lymphoma or solid tumors, this method of fertility preservation may be unsafe for patients with leukemia, according to a recent study published online in Blood, the journal of the American Society of Hematology…
No Comments »
Filed under: Women's Health
